<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; video</title>
	<atom:link href="http://www.tapanray.in/tag/video/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>3D Printing: An Emerging Game Changer in Pharma Business</title>
		<link>http://www.tapanray.in/3d-printing-an-emerging-game-changer-in-pharma-business/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=3d-printing-an-emerging-game-changer-in-pharma-business</link>
		<comments>http://www.tapanray.in/3d-printing-an-emerging-game-changer-in-pharma-business/#comments</comments>
		<pubDate>Mon, 11 Jan 2016 00:00:42 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[3d]]></category>
		<category><![CDATA[3DP]]></category>
		<category><![CDATA[API]]></category>
		<category><![CDATA[Aprecia]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[Changer]]></category>
		<category><![CDATA[Cronin]]></category>
		<category><![CDATA[discovery]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Lee]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[MIT]]></category>
		<category><![CDATA[Nanoscience and Chemical Complexity]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[printing]]></category>
		<category><![CDATA[Professor of Chemistry]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Supply]]></category>
		<category><![CDATA[Talk]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Ted]]></category>
		<category><![CDATA[video]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7393</guid>
		<description><![CDATA[On August 3, 2015, Aprecia Pharmaceuticals in the United States took a game changing step towards a new paradigm of the global pharma business. The Company  announced that for the first time ever, the U.S. Food and Drug Administration (US FDA) &#8230; <a href="http://www.tapanray.in/3d-printing-an-emerging-game-changer-in-pharma-business/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/3d-printing-an-emerging-game-changer-in-pharma-business/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Is Drug Innovation As Critical As Access To Medicines For All? [Augmented By A Video]</title>
		<link>http://www.tapanray.in/is-drug-innovation-as-critical-as-access-to-medicines-for-all-augmented-by-a-video/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=is-drug-innovation-as-critical-as-access-to-medicines-for-all-augmented-by-a-video</link>
		<comments>http://www.tapanray.in/is-drug-innovation-as-critical-as-access-to-medicines-for-all-augmented-by-a-video/#comments</comments>
		<pubDate>Mon, 12 May 2014 00:00:44 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[accelerating]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[AMP]]></category>
		<category><![CDATA[brain]]></category>
		<category><![CDATA[center]]></category>
		<category><![CDATA[clipping]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[credibility]]></category>
		<category><![CDATA[critical]]></category>
		<category><![CDATA[Demythologizing]]></category>
		<category><![CDATA[Drug]]></category>
		<category><![CDATA[dubious]]></category>
		<category><![CDATA[Fund]]></category>
		<category><![CDATA[have-nots]]></category>
		<category><![CDATA[Health]]></category>
		<category><![CDATA[IMPACT]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[logjam.]]></category>
		<category><![CDATA[Medicines]]></category>
		<category><![CDATA[model]]></category>
		<category><![CDATA[Open]]></category>
		<category><![CDATA[Partnership]]></category>
		<category><![CDATA[perpetuity]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Pogge]]></category>
		<category><![CDATA[PPP]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[rich]]></category>
		<category><![CDATA[smarter]]></category>
		<category><![CDATA[Social]]></category>
		<category><![CDATA[source]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Thomas]]></category>
		<category><![CDATA[Tuft]]></category>
		<category><![CDATA[Universal]]></category>
		<category><![CDATA[video]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=5372</guid>
		<description><![CDATA[To make important medicines available to all in a sustainable way, the renowned philosopher Thomas Pogge in this very interesting video clipping titled “Medicines For The 99 Percent” suggested the following three simple, yet critical, steps to effectively run the &#8230; <a href="http://www.tapanray.in/is-drug-innovation-as-critical-as-access-to-medicines-for-all-augmented-by-a-video/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/is-drug-innovation-as-critical-as-access-to-medicines-for-all-augmented-by-a-video/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
